HIV-1 Nef in Macrophage-Mediated Disease Pathogenesis

REFERENCES

• Richman DD, Little SJ, Smith DM, HIV evolution and escape. Trans Am Clin Climatol Assoc 2004;115:289–303.
   Google Scholar
• Le Douce V, Herbein G, Rohr O, Schwartz C. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 2010;7:32.
   Google Scholar
• Perno CF, Newcomb FM, Davis DA, Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J Infect Dis 1998;178(2):413–422.
   Google Scholar
• Aquaro S, Calio R, Balzarini J, Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res 2002;55(2):209–225.
   Google Scholar
• Lambotte O, Taoufik Y, de Goer MG, et al. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000;23(2):114–119.
   Google Scholar
• Zhu T, Muthui D, Holte S, Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002;76(2):707–716.
   Google Scholar
• Lamers SL, Salemi M, Galligan DC, Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS One 2009;4(3):e5065.
   Google Scholar
• Korber BT, Kunstman KJ, Patterson BK, Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68(11):7467–7481.
   Google Scholar
• Shapshak P, Segal DM, Crandall KA, Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retroviruses 1999;15(9):811–820.
   Google Scholar
• Williams KC, Corey S, Westmoreland SV, Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001;193(8):905–915.
   Google Scholar
• Almodovar S, Del CCM, Maldonado IM, HIV-1 infection of monocytes is directly related to the success of HAART. Virology 2007;369(1):35–46.
   Google Scholar
• Valcour VG, Shiramizu BT, Shikuma CM. HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol 2010;87(4):621–626.
   Google Scholar
• Salemi M, Lamers SL, Huysentruyt LC, Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PLoS One 2009;4(12):e8153.
   Google Scholar
• Novak RM, Richardson JT, Buchacz K, Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS 2012;26(6):721–730.
   Google Scholar
• Achenbach CJ, Cole SR, Kitahata MM, Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS 2011;25(5):691–700.
   Google Scholar
• Hogan C, Wilkins E. Neurological complications in HIV. Clin Med 2011;11(6):571–575.
   Google Scholar
• McGrath MS. T-cells and macrophages in HIV disease. Clin Rev Allergy Immunol 1996;14(4):359–366.
   Google Scholar
• Zack JA, Cann AJ, Lugo JP, Chen IS. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 1988;240(4855):1026–1029.
   Google Scholar
• Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373(6510):123–126.
   Google Scholar
• Swingler S, Brichacek B, Jacque JM, et al. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 2003;424(6945):213–219.
   Google Scholar
• Chan DJ. HIV-1 superinfection: evidence and impact. Curr HIV Res 2004;2(3):271–274.
   Google Scholar
• Lindwasser OW, Chaudhuri R, Bonifacino JS. Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med 2007;7(2):171–184.
   Google Scholar
• Olivetta E, Federico M. HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis. Exp Cell Res 2006;312(6):890–900.
   Google Scholar
• Swingler S, Mann AM, Zhou J, Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 2007;3(9):1281–1290.
   Google Scholar
• Herbein G, Varin A. The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 2010;7:33.
   Google Scholar
• Mujawar Z, Rose H, Morrow MP, Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol 2006;4(11):e365.
   Google Scholar
• Crowe SM, Westhorpe CL, Mukhamedova N, et al. The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol 2010;87(4):589–598.
   Google Scholar
• Tsang J, Chain BM, Miller RF, HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 2009 13;23(17):2255–2263.
   Google Scholar
• Huysentruyt LC, McGrath MS. The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma. J Leukoc Biol 2010;87(4):627–632.
   Google Scholar
• Burke B, Lewis C. The Macrophage. 2nd ed. Oxford: Oxford University Press; 2002.
   Google Scholar
• Wraith DC, Nicholson LB. The adaptive immune system in diseases of the central nervous system. J Clin Invest 2012;122(4):1172–1179.
   Google Scholar
• Cassol E, Cassetta L, Alfano M, Poli G. Macrophage polarization and HIV-1 infection. J Leukoc Biol 2010;87(4):599–608.
   Google Scholar
• Mantovani A, Sica A, Allavena P, et al. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol 2009;70(5):325–330.
   Google Scholar
• Sica A, Larghi P, Mancino A, Macrophage polarization in tumour progression. Semin Cancer Biol 2008;18(5):349–355.
   Google Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8(12):958–969.
   Google Scholar
• Piguet V, Trono D. The Nef protein of primate lentiviruses. Rev Med Virol 1999;9(2):111–120.
   Google Scholar
• Carl S, Greenough TC, Krumbiegel M, Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol 2001;75(8):3657–3565.
   Google Scholar
• Das SR, Jameel S. Biology of the HIV Nef protein. Indian J Med Res 2005;121(4):315–332.
   Google Scholar
• Henao-Mejia J, Liu Y, Park IW, Suppression of HIV-1 Nef translation by Sam68 mutant-induced stress granules and nef mRNA sequestration. Mol Cell 2009;33(1):87–96.
   Google Scholar
• Schindler M, Munch J, Kutsch O, Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006;125(6):1055–1067.
   Google Scholar
• Foster JL, Garcia JV. HIV pathogenesis: Nef loses control. Cell 2006;125(6):1034–1035.
   Google Scholar
• Robert-Guroff M, Popovic M, Gartner S, Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol 1990;64(7):3391–3398.
   Google Scholar
• Klotman ME, Kim S, Buchbinder A, Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A 1991;88(11):5011–5015.
   Google Scholar
• Choi HJ, Smithgall TE. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. J Mol Biol 2004;343(5):1255–1268.
   Google Scholar
• Lehmann MH, Walter S, Ylisastigui L, Extracellular HIV-1 Nef increases migration of monocytes. Exp Cell Res 2006;312(18):3659–3668.
   Google Scholar
• Ghiglione Y, Turk G. Nef performance in macrophages: the master orchestrator of viral persistence and spread. Curr HIV Res 2011;9(7):505–513.
   Google Scholar
• Brown A, Moghaddam S, Kawano T, Cheng-Mayer C. Multiple human immunodeficiency virus type 1 Nef functions contribute to efficient replication in primary human macrophages. J Gen Virol 2004;85(Pt 6):1463–1469.
   Google Scholar
• Collins KL, Chen BK, Kalams SA, HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391(6665):397–401.
   Google Scholar
• Chaudhry A, Verghese DA, Das SR, HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol 2009;183(4):2415–2424.
   Google Scholar
• Peterlin BM, Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 2003;3(2):97–107.
   Google Scholar
• Tachado SD, Li X, Swan K, Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro. J Biol Chem 2008;283(48):33191–33198.
   Google Scholar
• Matsubara M, Jing T, Kawamura K, Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. Protein Sci 2005;14(2):494–503.
   Google Scholar
• Coleman CM, Spearman P, Wu L. Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology 2011;8(1):26.
   Google Scholar
• Schindler M, Rajan D, Banning C, Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 2010;7:1.
   Google Scholar
• Sauter D, Kirchhoff F. Tetherin antagonism by primate lentiviral nef proteins. Curr HIV Res 2011;9(7):514–523.
   Google Scholar
• Lee CH, Saksela K, Mirza UA, Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 1996;85(6):931–942.
   Google Scholar
• Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010;7:34.
   Google Scholar
• Costa LJ, Chen N, Lopes A, Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology 2006;3:33.
   Google Scholar
• Lewis M, Lee P, Ng H, Yang O. Immune Selection in vitro reveals human immunodeficiency virus-1 nef sequence motifs important for its immune evasion function in vivo. J Virol 2012;86(13):7126–7135.
   Google Scholar
• Lewis MJ, Balamurugan A, Ohno A, Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo. J Immunol 2008;180(6):4075–4081.
   Google Scholar
• Poe JA, Smithgall TE. HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication. J Mol Biol 2009;394(2):329–342.
   Google Scholar
• Bentham M, Mazaleyrat S, Harris M. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J Gen Virol 2006;87(Pt 3):563–571.
   Google Scholar
• Giese SI, Woerz I, Homann S, Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology 2006;355(2):175–191.
   Google Scholar
• Foster JL, Denial SJ, Temple BR, Garcia JV. Mechanisms of HIV-1 Nef Function and Intracellular Signaling. J Neuroimmune Pharmacol 2011;6(2):230–246.
   Google Scholar
• Gerlach H, Laumann V, Martens S, HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat Chem Biol 2010;6(1):46–53.
   Google Scholar
• Coates K, Boulton V, Cooke S, Analysis of the interactions between Nef and cellular proteins. Res Virol 1997;148(1):68–70.
   Google Scholar
• Fackler OT, Kienzle N, Kremmer E, Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur J Biochem 1997;247(3):843–851.
   Google Scholar
• Kaminchik J, Margalit R, Yaish S, Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res Hum Retroviruses 1994;10(8):1003–1010.
   Google Scholar
• Niederman TM, Hastings WR, Ratner L. Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. Virology 1993;197(1):420–425.
   Google Scholar
• Lenassi M, Cagney G, Liao M, HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010;11(1):110–122.
   Google Scholar
• Shelton MN, Huang MB, Ali SA, Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 2012;86(1):406–419.
   Google Scholar
• Lamers SL, Fogel GB, Huysentruyt LC, McGrath MS. HIV-1 nef protein visits B-cells via macrophage nanotubes: a mechanism for AIDS-related lymphoma pathogenesis? Curr HIV Res 2010;8(8):638–640.
   Google Scholar
• Xu W, Santini PA, Sullivan JS, HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009;10(9):1008–1017.
   Google Scholar
• Rudnicka D, Schwartz O. Intrusive HIV-1-infected cells. Nat Immunol 2009;10(9):933–934.
   Google Scholar
• Moir S, Fauci AS. Nef, macrophages and B cells: a highway for evasion. Immunol Cell Biol 2010;88(1):1–2.
   Google Scholar
• Swingler S, Zhou J, Swingler C, Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 2008;4(1):63–76.
   Google Scholar
• Ng VL, Hurt MH, Herndier BG, VH gene use by HIV type 1-associated lymphoproliferations. AIDS Res Hum Retroviruses 1997;13(2):135–149.
   Google Scholar
• Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS 1994;8(8):1025–1049.
   Google Scholar
• Qiao X, He B, Chiu A, Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 2006;7(3):302–310.
   Google Scholar
• Lamers SL, Poon AF, McGrath MS. HIV-1 Nef protein structures associated with brain infection and dementia pathogenesis. PLoS One 2011;6(2):e16659.
   Google Scholar
• Klein D, Hurley LB, Quesenberry CP, Jr., Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002;30(5):471–477.
   Google Scholar
• Currier JS, Lundgren JD, Carr A, Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008;118(2):e29–e35.
   Google Scholar
• Hsue PY, Hunt PW, Schnell A, Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 2009;23(9):1059–1067.
   Google Scholar
• Estrada V, Portilla J. Dyslipidemia related to antiretroviral therapy. AIDS Rev 2011;13(1):49–56.
   Google Scholar
• Sprinz E, Lazzaretti RK, Kuhmmer R, Ribeiro JP. Dyslipidemia in HIV-infected individuals. Braz J Infect Dis 2010;14(6):575–588.
   Google Scholar
• Onen NF, Overton ET. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci 2011;4(1):33–41.
   Google Scholar
• Dressman J, Kincer J, Matveev SV, HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages. J Clin Invest 2003;111(3):389–397.
   Google Scholar
• Hammond E, McKinnon E, Nolan D. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. Clin Infect Dis 2010;51(5):591–599.
   Google Scholar
• Burdo TH, Lo J, Abbara S, Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011;204(8):1227–1236.
   Google Scholar
• Asztalos BF, Mujawar Z, Morrow MP, Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis 2010;202(4):614–623.
   Google Scholar
• Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obesity 2003;27(Suppl 3):S35–S40.
   Google Scholar
• Salemi M, Lamers S, Yu S, Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol 2005;79(17):11343–11352.
   Google Scholar
• Williams K, Corey S, Westmoreland S, Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001;193(8):905–916.
   PubMed Web of Science ®Google Scholar
• Williams KC, Hickey WF. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002;25:537–562.
   Google Scholar
• Qin C, Nagao T, Grosheva I, Elevated plasma membrane cholesterol content alters macrophage signaling and function. Arterioscler Thromb Vasc Biol 2006;26(2):372–378.
   Google Scholar
• Nagao T, Qin C, Grosheva I, Elevated cholesterol levels in the plasma membranes of macrophages inhibit migration by disrupting RhoA regulation. Arterioscler Thromb Vasc Biol 2007;27(7):1596–1602.
   Google Scholar
• Llodra J, Angeli V, Liu J, Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 2004;101(32):11779–11784.
   Google Scholar
• van't Wout AB, Swain JV, Schindler M, Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol 2005;79(15):10053–10058.
   Google Scholar
• Morrow MP, Grant A, Mujawar Z, Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol 2010;78(2):215–225.
   Google Scholar
• Koldamova R, Fitz NF, Lefterov I. The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. Biochim Biophys Acta 2010;1801(8):824–830.
   Google Scholar
• Suetani RJ, Sorrenson B, Tyndall JD, Homology modeling and functional testing of an ABCA1 mutation causing Tangier disease. Atherosclerosis 2011;218(2):404–410.
   Google Scholar
• Asztalos BF, Mujawar Z, Morrow MP, Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis 2010;202(4):614–623.
   Google Scholar
• Tsiodras S, Perelas A, Wanke C, Mantzoros CS. The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications. J Infect 2010;61(2): 101–113.
   Google Scholar
• Andersen O, Haugaard SB, Andersen UB, Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function. Metabolism 2003;52(10):1343–1353.
   Google Scholar
• Haugaard SB, Andersen O, Dela F, Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. Eur J Endocrinol 2005;152(1):103–112.
   Google Scholar
• Lamers SL, Salemi M, Galligan DC, Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol 2010;16(3):230–241.
   Google Scholar
• Snider WD, Simpson DM, Nielsen S, Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983;14(4):403–418.
   Google Scholar
• Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19(6):517–524.
   Google Scholar
• Antinori A, Arendt G, Becker JT, Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69(18):1789–1799.
   Google Scholar
• Budka H. The definition of HIV-specific neuropathology. Acta Pathol Jpn 1991;41(3):182–191.
   Google Scholar
• Budka H, Costanzi G, Cristina S, Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987;75(2):185–198.
   Google Scholar
• Budka H, Wiley CA, Kleihues P, HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1(3):143–152.
   Google Scholar
• Pumarola-Sune T, Navia BA, Cordon-Cardo C, HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987;21(5):490–496.
   Google Scholar
• Grant I, Atkinson JH, Hesselink JR, Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 1987;107(6):828–836.
   Google Scholar
• Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38(5):755–762.
   Google Scholar
• Masliah E, Heaton RK, Marcotte TD, Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997;42(6):963–972.
   Google Scholar
• Bell JE. The neuropathology of adult HIV infection. Rev Neurol (Paris) 1998;154(12):816–829.
   Web of Science ®Google Scholar
• Boni J, Emmerich BS, Leib SL, PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 1993;43(9):1813–1817.
   Google Scholar
• Bhaskaran K, Mussini C, Antinori A, Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 2008;63(2):213–221.
   Google Scholar
• Heaton RK, Clifford DB, Franklin DR, Jr., HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010;75(23):2087–2096.
   Google Scholar
• McArthur JC, McDermott MP, McClernon D, Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004;61(11): 1687–1696.
   Google Scholar
• Everall I, Vaida F, Khanlou N, Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 2009;15(5–6):360–370.
   Google Scholar
• Cherner M, Masliah E, Ellis RJ, Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 2002;59(10):1563–1567.
   Google Scholar
• Koedel U, Kohleisen B, Sporer B, HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J Immunol 1999;163(3):1237–1245.
   Google Scholar
• Annunziata P. Blood–brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J Neurol 2003;250(8):901–906.
   Google Scholar
• Bergonzini V, Calistri A, Salata C, Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia. J Neurovirol 2009;15(3):238–248.
   Google Scholar
• Fiala M, Rhodes RH, Shapshak P, Regulation of HIV-1 infection in astrocytes: expression of Nef, TNF-alpha and IL-6 is enhanced in coculture of astrocytes with macrophages. J Neurovirol 1996;2(3):158–166.
   Google Scholar
• Lehmann MH, Masanetz S, Kramer S, Erfle V. HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. J Cell Sci 2006;119(Pt 21):4520–4530.
   Google Scholar
• van Marle G, Henry S, Todoruk T, Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 2004;329(2):302–318.
   Google Scholar
• Davis LE, Hjelle BL, Miller VE, Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42(9):1736–1739.
   Google Scholar
• Georgsson G, Stahl-Hennig C, Tenner-Racz K, The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus deltanef. Neuropathol Appl Neurobiol 2007;33(6):644–657.
   Google Scholar
• Alter G, Suscovich TJ, Teigen N, Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol 2007;178(12):7658–7666.
   Google Scholar
• Zhao L, Galligan DC, Lamers SL, High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. Sci China C Life Sci 2009;52(7):651–656.
   Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008;65(1):65–70.
   Google Scholar
• Harezlak J, Buchthal S, Taylor M, Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 2011;25(5):625–633.
   Google Scholar
• Bingham R, Ahmed N, Rangi P, HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS 2011;22(10):608–609.
   Google Scholar
• Fischer-Smith T, Croul S, Sverstiuk AE, CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001;7(6):528–541.
   Google Scholar
• Kumar S, Jack R. Origin of monocytes and their differentiation to macrophages and dendritic cells. J Endotoxin Res 2006;12(5):278–284.
   Google Scholar
• Williams K, Alvarez X, Lackner AA. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 2001;36(2):156–164.
   Google Scholar
• Pulliam L, Gascon R, Stubblebine M, Unique monocyte subset in patients with AIDS dementia. Lancet 1997;349(9053):692–695.
   Google Scholar
• Ancuta P, Kamat A, Kunstman KJ, Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008;3(6):e2516.
   Google Scholar
• Lyons JL, Uno H, Ancuta P, Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr 2011;57(5):371–379.
   Google Scholar
• Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 2011;1399:96–115.
   Google Scholar
• Eugenin EA, Osiecki K, Lopez L, CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and neuroAIDS. J Neurosci 2006;26(4):1098–1106.
   Google Scholar
• Eugenin EA, Gamss R, Buckner C, Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of neuroAIDS. J Leukoc Biol 2006;79(3):444–452.
   Google Scholar
• Muratori C, Sistigu A, Ruggiero E, Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9. J virol [Research Support, Non-U.S. Gov't] 2007;81(17):9078–9087.
   Google Scholar
• Zink MC, Brice AK, Kelly KM, Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis 2010 ;202(1):161–170.
   Google Scholar
• Bergamini A, Faggioli E, Bolacchi F, Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1. J Infect Dis 1999;179(4):832–842.
   Google Scholar
• Brew BJ, Bhalla RB, Paul M, Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 1990;28(4):556–560.
   Google Scholar
• Yao H, Bethel-Brown C, Li CZ, Buch SJ. HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol [Research Support, N.I.H., Extramural Review] 2010;5(4): 489–495.
   Google Scholar
• Sui Y, Stehno-Bittel L, Li S, CXCL10-induced cell death in neurons: role of calcium dysregulation. Eur J Neurosci [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't] 2006;23(4):957–964.
   Google Scholar
• Smith DG, Guillemin GJ, Pemberton L, Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol [Research Support, Non-U.S. Gov't] 2001;7(1):56–60.
   Google Scholar
• Xiong H, Zeng YC, Zheng J, Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia. J Neurovirol [In Vitro Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] 1999;5(5):519–528.
   Web of Science ®Google Scholar
• Garden GA. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 2002;40(2):240–251.
   Google Scholar
• Gray F, Scaravilli F, Everall I, Neuropathology of early HIV-1 infection. Brain Pathol 1996;6(1):1–15.
   Google Scholar
• Meisner F, Neuen-Jacob E, Sopper S, Disruption of excitatory amino acid transporters in brains of SIV-infected rhesus macaques is associated with microglia activation. J Neurochem 2008;104(1):202–209.
   Google Scholar
• Rostasy K, Monti L, Yiannoutsos C, Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann Neurol [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] 1999;46(2):207–216.
   Google Scholar
• Field R, Campion S, Warren C, Systemic challenge with the TLR3 agonist poly I:C induces amplified IFN-alpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun 2010;24(6):996–1007.
   Google Scholar
• Kitazawa M, Oddo S, Yamasaki TR, Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005;25(39):8843–8853.
   Google Scholar
• Gavett BE, Stern RA, McKee AC. Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med 2011;30(1):179–188, xi.
   Google Scholar
• Maccioni RB, Munoz JP, Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 2001;32(5):367–381.
   Google Scholar
• DeKosky ST, Ikonomovic MD, Gandy S. Traumatic brain injury–football, warfare, and long-term effects. N Engl J Med 2010;363(14):1293–1296.
   Google Scholar
• Gisslen M, Krut J, Andreasson U, Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 2009;9:63.
   Google Scholar
• Kadiu I, Nowacek A, McMillan J, Gendelman HE. Macrophage endocytic trafficking of antiretroviral nanoparticles. Nanomedicine (Lond) 2011;6(6):975–994.
   Google Scholar
• Haughey NJ, Bandaru VV, Bae M, Mattson MP. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim Biophys Acta 2010;1801(8):878–886.
   Google Scholar
• Thompson KA, Kent SJ, Gahan ME, Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus. J Neurovirol 2003;9(4):442–451.
   Google Scholar
• Clarke S, Berry N, Ham C, Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques. J Neurovirol 2012;18(2):100–112.
   Google Scholar
• Werner T, Ferroni S, Saermark T, HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS 1991;5(11):1301–1308.
   Google Scholar
• Ranki A, Nyberg M, Ovod V, Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS [Research Support, Non-U.S. Gov't] 1995;9(9):1001–1008.
   Web of Science ®Google Scholar
• Mordelet E, Kissa K, Cressant A, Histopathological and cognitive defects induced by Nef in the brain. FASEB J [Research Support, Non-U.S. Gov't] 2004;18(15):1851–1861.
   Google Scholar
• Acheampong EA, Parveen Z, Muthoga LW, Human immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J virolo [Research Support, U.S. Gov't, P.H.S.] 2005;79(7):4257–4269.
   Web of Science ®Google Scholar
• Acheampong EA, Roschel C, Mukhtar M, Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis. J Virol 2009;6:183.
   Google Scholar
• Sporer B, Koedel U, Paul R, Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 2000;102(2):125–130.
   Google Scholar
• Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr HIV Res 2003;1(2):167–184.
   Google Scholar
• Zheng J, Thylin MR, Ghorpade A, Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.] 1999;98(2):185–200.
   Web of Science ®Google Scholar
• Overholser ED, Coleman GD, Bennett JL, Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J Virol [Research Support, U.S. Gov't, P.H.S.] 2003;77(12):6855–6866.
   Google Scholar
• Olivetta E, Percario Z, Fiorucci G, HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol [Research Support, Non-U.S. Gov't] 2003;170(4):1716–1727.
   PubMed Web of Science ®Google Scholar
• Murray EA, Rausch DM, Lendvay J, Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992;255(5049):1246–1249.
   Google Scholar
• Sacktor N, Nakasujja N, Skolasky RL, HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 2009;49(5):780–786.
   Google Scholar
• Salemi M, Lamers SL, Yu S, Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol 2005;79(17):11343–11352.
   Google Scholar
• Strickland SL, Gray RR, Lamers S, Efficient transmission and persistence of low frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology. J Gen Virol 2012;93(Pt 5):925–938.
   Google Scholar
• Olivieri KC, Agopian KA, Mukerji J, Gabuzda D. Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Res Hum Retroviruses 2010;26(4):495–500.
   Google Scholar
• Gray LR, Gabuzda D, Cowley D, CD4 and MHC class I down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates. J Neurovirol 2011;17(1):82–91.
   Google Scholar
• Singh DK, McCormick C, Pacyniak E, A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype. Virology 2001;282(1):123–140.
   Google Scholar
• Brumme ZL, Brumme CJ, Heckerman D, Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 2007;3(7):e94.
   Google Scholar